Outset Medical, Inc. (OM) vs Sera Prognostics, Inc. (SERA)
Outset Medical, Inc. and Sera Prognostics, Inc. are both Medical Devices companies. Sera Prognostics, Inc. is the larger, with a market value of $83.2M against $58.8M — 1.4× the size. Outset Medical, Inc. grew revenue faster over the last twelve months: −1.26% against −35.2%. Outset Medical, Inc. has the higher net margin (−63.1% vs −47,475.7%) and the higher return on invested capital (−86.1% vs −180.2%). Across the 18 metrics below, Outset Medical, Inc. leads on 12 and Sera Prognostics, Inc. on 6.
Valuation
Profitability
| Metric | OM | SERA | Medical Devices median |
|---|---|---|---|
| Gross margin | 41.76% | (150.00%) | 56.01% |
| Operating margin | (56.06%) | (53,282.86%) | (15.03%) |
| Net margin | (63.06%) | (47,475.71%) | (20.40%) |
| Free cash flow margin | (33.00%) | (40,760.00%) | (7.24%) |
| Return on equity | (60.09%) | (45.03%) | (15.32%) |
| Return on assets | (27.97%) | (33.47%) | (19.72%) |
| Return on invested capital | (86.10%) | (180.22%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack